Marker Therapeutics (MRKR) Q3 2026 Earnings

13AugConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.36
-0.28
-0.2
-0.12

Details

Expected EPS
-0.217
Actual EPS
N/A
Surprise EPS
0.22
Surprise Percent
+100%

Description

Marker Therapeutics (MRKR) will report earnings of for Q3 2026 on August 13, 2026.

0 Comments

Share your thoughts